Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Kyndryl Holdings Inc (KD) vs Nuwellis Inc (NUWE) Price & Performance

Kyndryl Holdings IncTrade
Nuwellis IncTrade

Price performance (Past 24H)

Key statistics

Kyndryl Holdings Inc vs Nuwellis Inc — how do they compare? Kyndryl Holdings Inc trades at $13.43 (market cap $2.97B), while Nuwellis Inc trades at $1.51 (market cap $522.76K). The key difference: Kyndryl Holdings Inc is far larger — about 5681.4× Nuwellis Inc's market cap, and Kyndryl Holdings Inc is trading nearer its 52-week high, Nuwellis Inc nearer its low. Which is the better fit depends on your goals.

KDNUWE
Market Cap
$2.97B$522.76K
Sector
TechnologyTechnology
52-Week High
$33.14$220.50
52-Week Low
$10.59$1.42
Enterprise Value
$5.79B-$1.29M

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Kyndryl Holdings Inc

Kyndryl (KD) trades at $14.02, showing modest daily gains of 0.21%. The stock maintains a bullish technical signal with strong moving average support. Fundamentally, the company achieved profitability in 2025 with $252M net income after three years of losses, though revenue declined to $15.1B. Recent developments include the planned acquisition of Healthcare IT Leaders to boost AI capabilities and Q1 2027 results showing a $0.12 per share loss on $3.6B revenue.

While Kyndryl demonstrates improving profitability and strategic AI investments, investors face mixed signals with analyst consensus leaning hold (71%) and revenue declines. The stock trades near analyst targets with upside limited to technical momentum. Key risks include ongoing revenue pressure and the integration challenges of recent acquisitions.

Nuwellis Inc

NUWE trades at $1.49, down 8.59% over the past day, with a bearish technical outlook. The company reported a net loss of $17.52M in 2025, with a negative net income margin of -217.22%, though it has shown revenue growth and recent strategic expansions in pediatric care. A recent 35:1 reverse stock split was executed on June 26, 2026.

The outlook remains high-risk due to persistent losses and cash burn, but growth initiatives and new product development offer potential. Key risks include execution challenges and dependence on financing. Analyst sentiment is mixed, with a 50% buy and 50% hold rating among covered analysts.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Kyndryl Holdings Inc

Kyndryl Holdings Inc is a technology services and infrastructure services provider company. It provides advisory, implementation, and managed services across a range of technology domains to help customers manage and modernize enterprise IT environments in support of their business and transformation objectives.

Read more on KD

About Nuwellis Inc

Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.

Read more on NUWE